Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation

TRAF5 [tumor necrosis factor (TNF) receptor-associated factor 5] is implicated in NF-κB and c-Jun NH 2 -terminal kinase/stress-activated protein kinase activation by members of the TNF receptor superfamily, including CD27, CD30, CD40, and lymphotoxin-β receptor. To investigate the functional role of...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 96; no. 17; pp. 9803 - 9808
Main Authors: Nakano, H, Sakon, S, Koseki, H, Takemori, T, Tada, K, Matsumoto, M, Munechika, E, Sakai, T, Shirasawa, T, Akiba, H, Kobata, T, Santee, S M, Ware, C F, Rennert, P D, Taniguchi, M, Yagita, H, Okumura, K
Format: Journal Article
Language:English
Published: United States National Acad Sciences 17-08-1999
National Academy of Sciences
The National Academy of Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:TRAF5 [tumor necrosis factor (TNF) receptor-associated factor 5] is implicated in NF-κB and c-Jun NH 2 -terminal kinase/stress-activated protein kinase activation by members of the TNF receptor superfamily, including CD27, CD30, CD40, and lymphotoxin-β receptor. To investigate the functional role of TRAF5 in vivo , we generated TRAF5-deficient mice by gene targeting. Activation of either NF-κB or c-Jun NH 2 -terminal kinase/stress-activated protein kinase by tumor necrosis factor, CD27, and CD40 was not abrogated in traf5 −/− mice. However, traf5 −/− B cells showed defects in proliferation and up-regulation of various surface molecules, including CD23, CD54, CD80, CD86, and Fas in response to CD40 stimulation. Moreover, in vitro Ig production of traf5 −/− B cells stimulated with anti-CD40 plus IL-4 was reduced substantially. CD27-mediated costimulatory signal also was impaired in traf5 −/− T cells. Collectively, these results demonstrate that TRAF5 is involved in CD40- and CD27-mediated signaling.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
To whom reprint requests should be addressed. E-mail: hnakano@med.juntendo.ac.jp.
Edited by Elliott D. Kieff, Harvard University, Boston, MA, and approved June 23, 1999
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.96.17.9803